Price Schedule-Donor Testing Services rev.xlsx
XLSX spreadsheet 19 KB Posted
- Solicitation number
- 22-000029
View the file
Other files
| File | Type | Posted |
|---|---|---|
| SOW_03242022.docx | DOCX document | |
| Invoicing Instructions 20220401.pdf | ||
| Tech Eval Criteria.pdf | ||
| HHS Subcontracting Plan Template.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Price Schedule
| SCHEDULE OF SUPPLIES AND SERVICES - DONOR TESTING SERVICES | SCHEDULE OF SUPPLIES AND SERVICES - DONOR TESTING SERVICES | |||||||||||
| Period: One Year Base Period and Four (12 month Option Periods) | Estimated Volume | Base Yr Price Per Test | Opt 1 Price Per Test | Opt 2 Price Per Test | Opt 3 Price Per Test | Opt 4 Price Per Test | Base Yr Price Per Test x Estimated Volume | Opt 1 Price Per Test x Est. Volume | OPT 2 Price Per Test x Est. Volume | OPT 3 Price Per Test x Est. Volume | Opt 4 Price Per Test x Est. Volume | |
| Description |
| Routine Donor Lab | ||
| Routine donor panel 1 | 8000 | 8000 |
| HCTP donor panel 2 | 250 | 250 |
| Viral marker Panel 3 | 1000 | 1000 |
| Chagas Testing | 1000 | 250 |
| chagas testing HCTP | 250 | 232 |
| Trali HLA | 200 | 1000 |
| IDS WNV virus (trigger) | 300 | 400 |
| HCTP CMV | 15 | 5300 |
| Babesia | 4000 | 4000 |
| Babesia (HCTP) | 250 | 250 |
| CMV | 232 | 232 |
| Leuko Reduced WBC | 1603 | 1603 |
| Special Testing Laboratory | ||
| Retrovirus Related Testing: | ||
| Anti-HIV-1/2 Plus O | 10 | |
| Geenius HIV-1/2 Supplemental Assay | 2 | |
| Anti-HTLV-I/II, MP Western Blot | 5 | |
| Anti-HTLV-I/II | 1 |
| Hepatitis Related Testing: | |
| HBsAg (Hepatitis B Surface Antigen) | 1 |
| HBsAg Neutralization (EIA) | 1 |
| Anti-HBs (Hepatitis B Surface Antibody) | 1 |
| Anti-HBc (Hepatitis B Core Antibody) | 1 |
| Anti-HCV (Hepatitis C Antibody - EIA) | 3 |
| Anti-HBc IgM* | 1 |
| Syphilis Serology | |
| Syphilis Screen - MHA-TP or RPR | 100 |
| Syphilis G EIA | 10 |
| Panels: | |
| Profile A (HBsAg, HIV-1/2, HCV) | 1 |
| Profile B (HBsAg, HIV-1/2, HCV, HTLV-I/II) | 500 |
| Profile C (HBsAg, HBc, HIV-1/2, HCV, HTLV-I/II) | 1 |
| Profile D (HBsAg, HBc, HIV-1/2, HCV, HTLV, HIV/HCV/HBV NAT IDS) | 500 |
| Profile F (HBsAg, HBc, HIV-1/2, HCV, HTLV, HIV/HCV/HBV NAT IDS, MHA-TP) | 1 |
| Profile G (HBsAg, HBc, HIV-1/2, HCV, HTLV, HIV/HCV/HBV NAT IDS, WNV NAT IDS) | 1 |
| Profile H (HBsAg, HBc, HIV-1/2, HCV, HTLV, HIV/HCV/HBV NAT IDS, WNV NAT IDS, ABO/Rh, MHA-TP, T. Cruzi, CMV) | 1 |
| HBC/HBsAg Reentry Donor Profile (HIV-1/2, HTLV-I/II, HBsAG, HBc, HCV, HIV-1/HCV/HBV NAT IDS, WNV NAT IDS, RPR, CMV, ABO/Rh, Antibody Screen, Replicate HBV NAT if indicated) | 5 |
| HIV Reentry Donor Profile (HBsAg, HBc, HIV-1/2, HCV, HTLV, HIV/HCV/HBV NAT IDS, WNV NAT IDS, ABO/Rh, Ab Screen, MHA-TP, CMV, dHIV NAT) | 5 |
| HCV Reentry Donor Profile (HBsAg, HBc, HIV-1/2, HCV, HTLV, HIV/HCV/HBV NAT IDS, WNV NAT IDS, ABO/Rh, Ab Screen, MHA-TP, CMV, dHCV NAT) | 10 |
| HBV Reentry Donor Profile (HBsAg, HBc, HIV-1/2, HCV, HTLV, HIV/HCV/HBV NAT IDS, WNV NAT IDS, ABO/Rh, Ab Screen, MHA-TP, CMV, dHBV NAT) | 5 |
| T. cruzi Reentry Donor Profile (HBsAg, HBc, HIV-1/2, HCV, HTLV-I/II, HIV/HCV/HBV NAT IDS, WNV NAT IDS, ABO/Rh, Ab Screen, MHA-TP, CMV, T. cruzi EIA, T. cruzi ChLIA) | 0 |
| HTLV Reentry Donor Profile (HBsAg, HBc, HIV-1/2, HCV, HTLV-I/II EIA, HTLV-I/II CMIA, HIV-1/HCV/HBV NAT IDS, WNV NAT IDS, MHA-TP, CMV, ABO/Rh, Antibody Screen) | 1 |
| Syphilis Reentry Donor Profile (HBsAg, HBc, HIV-1/2, HCV, HTLV-I/II, HIV-1/HCV/HBV NAT IDS, WNV NAT IDS, MHA-TP, CMV, ABO/Rh, Antibody Screen) | 0 |
| Nucleic Acid Testing (NAT) | |
| HIV-1/HCV/HBV NAT IDS (includes discriminatory testing as needed) | 1 |
| HIV-1/HCV/HBV NAT, COBAS TaqScreen MPX 2.0 | 1 |
| WNV NAT IDS | 1 |
| Novartis HBV (TMA) NAT (dHBV) | 1 |
| Novartis HCV (TMA) NAT (dHCV) | 1 |
| Novartis HIV (TMA) NAT (dHIV) | 1 |
| Replicate HBV NAT (for Anti-HBc donor reentry) | 1 |
| Novartis Babesia NAT IDS | 1 |
| Other Tests: | ||||||
| ABO/Rh | 100 | |||||
| Antibody Screen | 10 | |||||
| Anti-T. cruzi EIA* | 10 | |||||
| Abbott ESA Chagas | 5 | |||||
| Abbott Alinity s HIV-1/2 Plus 0 Combo (Ag/Ab)* | 1 | |||||
| Abbott Alinity s HTLV I/II* | 1 | |||||
| Abbott Alinity s HBsAg* | 1 | |||||
| Abbott Alinity s HBsAg Neutralization* | 1 | |||||
| Abbott Alinity s HBc* | 1 | |||||
| Abbott Alinity s HCV* | 1 | |||||
| Abbott Alinity s Chagas* | 1 | |||||
| CMV | 10 | |||||
| EBV Antibody to Nuclear Antigen* | 1 | |||||
| Toxoplasma IgG* | 1 | |||||
| WNV IgM/IgG* | $ | 1 | ||||
| TOTAL | $ | $ | $ | $ |
File details come from the government source that posted it. Updated .